San Diego, CA, United States of America

Gothami Padmabandu

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Gothami Padmabandu: Innovator in Nucleic Acid Quantification

Introduction

Gothami Padmabandu is a prominent inventor based in San Diego, California. She has made significant contributions to the field of nucleic acid quantification, holding a total of six patents. Her innovative work focuses on improving methods for detecting and quantifying target nucleic acids in various samples.

Latest Patents

One of Gothami's latest patents is a system and method for determining copies-per-unit-volume using PCR and flow control of droplets. This method provides a comprehensive approach for quantifying target nucleic acids in a sample. It involves forming discrete sample portions, amplifying them, and detecting fluorescence signals to determine the presence of target nucleic acids. The method also estimates the number of copies-per-unit-volume based on the processed sample portions that contain the target nucleic acid.

Career Highlights

Throughout her career, Gothami has worked with notable companies such as Life Technologies Corporation and Agilent Technologies, Inc. Her experience in these organizations has allowed her to develop and refine her innovative techniques in nucleic acid quantification.

Collaborations

Gothami has collaborated with esteemed colleagues, including Gordon A. Janaway and Mark R. Andersen. These collaborations have further enhanced her research and development efforts in the field.

Conclusion

Gothami Padmabandu is a trailblazer in the realm of nucleic acid quantification, with a strong portfolio of patents and a rich career history. Her contributions continue to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…